PPD completes Evidera acquisition, committed to seamless integration

By Melissa Fassbender contact

- Last updated on GMT

Evidera’s real world research services will further strengthen PPD’s peri- and post-approval capabilities. (Image: iStock/Nastco)
Evidera’s real world research services will further strengthen PPD’s peri- and post-approval capabilities. (Image: iStock/Nastco)

Related tags: Subsidiary

Pharmaceutical Product Development, LLC (PPD), has announced the completed acquisition of Evidera as the two companies commit to making the “seamless offering a reality.”

As Outsourcing-Pharma.com previously reported, the contract research organization (CRO) announced the acquisition​ in August of this year, citing the growing need for real-world data.

Jon Williams, president of Evidera, told us the closing the acquisition went smoothly, taking less than four weeks from signing.

We’re aligning the PPD and Evidera teams to uncover opportunities to more effectively generate, interpret and communicate real-world evidence on behalf of our clients​,” he added.

Together, Williams said PPD and Evidera will deliver “comprehensive development strategies​” that will help its clients earn regulatory approval and generate the real-world evidence needed for pricing and reimbursement discussions, as well as for optimized market access. 

Over the coming weeks and months we will create the necessary points of connection and operational processes to make this seamless offering a reality​,” Williams explained.

Evidera will operate as a wholly owned subsidiary of PPD, though Williams said the newly combined company will maintain Evidera’s culture and focus on scientific excellence and thought leadership in real-world research, “while also working very closely with our new parent company​,” he explained.

We expect that PPD’s world-class global operations and regulatory expertise combined with our unparalleled capabilities in the late phase and market access space will not only be a unique asset, but will serve as a unifying force that will bring the two companies together to offer a powerful set of solutions​,” added Williams.

Above all, we are committed to achieving a seamless integration with no loss of focus on innovation, industry leadership and client service​.”

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Related suppliers

Follow us

Products

View more

Webinars